Phase 4 Depression and Anxiety Trial, Not Yet Recruiting NCT06644833 Sponsor: Sultan Qaboos University Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Not Yet Recruiting

NCT06644833
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 to 64 who have been diagnosed with their first or second episode of major depression (also called unipolar major depressive disorder).
  • People whose depression is rated as moderate to severe based on clinical assessment and standard measurement tools.
  • People who are willing to take part and sign a written consent form.
  • People who are currently being treated as outpatients (not currently staying in a hospital or psychiatric facility for mental health reasons).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose current episode of major depression is not their first or second episode.
  • People who have had a problem with alcohol or drug dependence or misuse in the past 6 months.
  • People who have been diagnosed with psychotic depression, bipolar disorder, or a condition involving catatonic features (a specific set of physical and mental symptoms — confirm with trial site).
  • People whose depression is severe enough that their doctor recommends electroconvulsive therapy (ECT), a medical treatment that uses electrical stimulation.
  • People assessed by a clinician as being at high risk of suicide.
  • People who have previously tried TMS (transcranial magnetic stimulation, a type of brain stimulation therapy) and did not respond well to it.
  • People who have epilepsy or are considered at high risk of developing epilepsy (confirm with trial site).
  • Women who are pregnant or breastfeeding, unless a neurologist has cleared them to receive TMS treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Sultan Qaboos University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 December 2028

Primary endpoints

Remission and Response rates between the two arms; Remission and Response rates between the two arms; Remission and Response rates between the two arms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov